• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconTeva

Teva

Page 2 of 2
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
FinanceBiotech Stocks Crashed and Nobody Knows Why
By Jen WiecznerJanuary 28, 2016
Pfizer employees inside of a laboratory at Pfizer's research and development facility in Cambridge, Massachusetts, U.S., on Monday, Oct. 26, 2015. Photographer: Scott Eisen/Bloomberg *** Local Caption ***
FinanceWhy Pfizer Is Headed for Splitsville After Allergan Merger
By Jen WiecznerNovember 19, 2015
14th Annual Elton John AIDS Foundation An Enduring Vision Benefit - Show
FinanceWhy Mylan Just Lost The Largest Hostile Takeover Battle Ever
By Jen WiecznerNovember 13, 2015
Mylan Buys Abbott Laboratories Generic Drug Business For $5.3 Billion
HealthMylan’s Hostile Bid for Perrigo Fails
By ReutersNovember 13, 2015
A Teva Pharmaceutical Industries factory in Jerusalem, Israel.
FinanceThe real reasons for the pharma merger boom
By Jen WiecznerJuly 28, 2015
Inside Teva Pharmaceuticals Headquarters
CommentaryTeva buys Allergan: 3 reasons why it’s a blockbuster deal
By S. KumarJuly 27, 2015
1
  • 1
  • 2
2
Most Popular
Success
In 2026, many employers are ditching merit-based pay bumps in favor of ‘peanut butter raises’An image of a popular article
By Emma BurleighFebruary 2, 2026
Economy
Trump may have shot himself in the foot at the Fed, as Powell could stay on while Miran resigns from White House postAn image of a popular article
By Eleanor PringleFebruary 4, 2026
Cybersecurity
Top AI leaders are begging people not to use Moltbook, a social media platform for AI agents: It’s a ‘disaster waiting to happen’An image of a popular article
By Eva RoytburgFebruary 2, 2026
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.